-
defence at the Faculty of Medicine, Vrije Universiteit Amsterdam. Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page . As a doctoral
-
. These families may face uncertainty about when symptoms will develop and difficult decisions about treatment. Understanding their experiences and support needs is important for developing patient-centred screening
-
, for example through newborn screening, family screening or genetic testing. These families may face uncertainty about when symptoms will develop and difficult decisions about treatment. Understanding
-
patients and families and learn about the priorities of affected communities. The position is based in Tübingen, Germany, with academic enrolment through the Eberhard Karls University of Tübingen. You will
-
, the University of Ghana, and Kenya Medicral Research Institute. Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page . The PhD student will
-
(ALC), Amsterdam UMC. The position is primarily based at InnoSer in Leiden, with regular academic interaction with the Amsterdam Leukodystrophy Center in Amsterdam. This includes approximately one day
-
multidisciplinary network of researchers within the departments of Molecular Cell Biology & Immunology and Pathology at Amsterdam UMC. Would you like to know more about the different phases within the PhD trajectory
-
Doctoral Network and host-organisation rules. More detailed information about the salary will follow; Embedding in the international POLARIS doctoral training network; Access to network-wide training
-
with the European Leukodystrophy Association (ELA) will offer the opportunity to engage with patients and families and learn about the priorities of affected communities. The position is based in
-
insights into coronary anatomy, blood flow, pressure, and wall shear stress—together with information about model uncertainty—the project aims to support more precise, physiology-guided treatment decisions